Drugs / 18F-C-SNAT4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04017819 | Mar 2024 → May 2026 | lung cancer | Stanford University | Suspended | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-C-SNAT4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04017819 ↗ |
| Modality | Diagnostic / imaging agent | “as an imaging agent” NCT04017819 ↗ |